Evidence map›Paper›PMID 37676040›Full record

SynthesisInternational journal of stroke : official journal of the International Stroke Society2023

Systematic review: Pharmacological interventions for the treatment of post-stroke fatigue.

Shuk Han Chu, Xu Zhao, Ahmad Komber, Joshua Cheyne, Simiao Wu, Eileen Cowey, Mansur Kutlubaev, Gillian Mead

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in International journal of stroke : official journal of the International Stroke Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Are central and systemic inflammation associated with fatigue in cerebral small vessel disease?International journal of stroke : official journal of the International Stroke Society · 2024
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuk Han ChuUsher Institute, The University of Edinburgh, Edinburgh, UK.ORCID 0009-0001-7042-885X
Xu ZhaoDepartment of Chemistry, Oxford University, Oxford, UK.
Ahmad KomberUsher Institute, The University of Edinburgh, Edinburgh, UK.
Joshua CheyneLibrary Services, University of the West of Scotland, Paisley, UK.
Simiao WuDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-4557-7386
Eileen CoweyNursing & Health Care School, University of Glasgow, Glasgow, UK.
Mansur KutlubaevDepartment of Neurology, Bashkir State Medical University, Ufa, Russia.
Gillian MeadUsher Institute, The University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-7494-2023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPost-stroke fatigue (PSF) affects around 50% of stroke survivors. Previous systematic reviews of randomized controlled trials found insufficient evidence to guide practice, but most excluded Chinese studies. Furthermore, their searches are now out-of-date.

aimsTo systematically review and perform a meta-analysis of randomized placebo-controlled trials of pharmacological interventions for treating PSF.

methodsWe screened Airitri, CNKI, VIP, CINAHL, ClinicalTrials.gov, CENTRAL, Cochrane Stroke Group Trial Register, EMBASE, EU Clinical Trial Register, ISRCTN, MEDLINE, PsycINFO, Wanfang, and WHO ICTRP up to 11 November 2022. Our primary outcome was fatigue severity. We conducted subgroup analysis by drug type and sensitivity analysis after excluding the trials at high risk of bias. Secondary outcomes included mood and quality of life.

resultsWe screened 33,297 citations and identified 10 published completed trials, 6 unpublished completed trials, and 6 ongoing trials. Pharmacological treatments were associated with lower fatigue severity at the end of treatment (10 published completed trials, 600 participants, pooled standardized mean difference (SMD) = -0.80, 95% confidence interval (CI): -1.29 to -0.31; I

conclusionThere is insufficient evidence to support a particular pharmacological treatment for PSF, thus current clinical guidelines do not require amendment.

Indexed as

StrokeFatigueHumansQuality of Lifeclinical trialfatiguepharmacological interventionRCTstroke careStroke rehabilitation

Identifiers

PMID37676040
PMCPMC10614171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.